HumeCare+ Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 5.7/10
Best for: an oral route if you will not self-inject
HumeCare+ falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
Plans open from $199/mo, billed month by month and cancellable whenever, and both the drug and the hardware sit inside that. HumeCare+ comes from Hume Health, the company that sells body-composition scales, and the logic follows: clinician-prescribed compounded GLP-1 semaglutide arrives with a Hume Pod, so the patient can watch whether the weight leaving is fat or muscle. Which states it serves is unpublished, and the marketing site identifies neither the prescribing medical group nor the pharmacy.
Is HumeCare+ legit?
Yes. HumeCare+ is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 5.7/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a HumeCare+ promo or coupon code?
We know of no promo or coupon code for HumeCare+. Its listed price is $199 a month. Coupon sites advertising "HumeCare+ discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how HumeCare+ compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
HumeCare+ at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide
- Starting price
- $199/mo
- What's included
- Medication · Consult
- FDA status
- No FDA warning letters found
How HumeCare+ scores
Six columns, each one computed from something HumeCare+ has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.5/10$199/month is 8% above the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
4.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.5/10The price covers the medication and clinician visits.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on HumeCare+
Last checked August 2026- Checked the listed price across 3 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for HumeCare+
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with HumeCare+ involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1HumeCare+ shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask HumeCare+ which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and clinician visits.
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $299. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that HumeCare+ serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting HumeCare+
- HumeCare+ offers email support
Cancelling HumeCare+
Taken from the terms HumeCare+ publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Not published by the seller
- Early-termination fee
- None
GLP-1 medications HumeCare+ offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Shown at checkout after the intake questionnaire: $199/mo charged, with $299 struck through and 'SAVE $100.' HumeCare+ does not say whether $299 is a regular rate anyone pays or only a reference price.
At checkout after intake: $299/mo charged, $399 struck through. Sold as a combination with vitamin B12 and glycine rather than tirzepatide alone.
At checkout after intake: $199/mo charged, $299 struck through.
Check the price yourself before you pay
Every figure here was read off HumeCare+'s own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- The monthly price includes the medication and clinician visits
- We found no FDA warning letters issued to HumeCare+
- Offers both oral and injectable options, so the format is your choice
Against it
- Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What HumeCare+ charges
HumeCare+ lists $199/month.
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $299/month
- Oral semaglutide: $199/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so HumeCare+'s $199 lands mid-market. Price is unlikely to be the deciding factor.
RNK Health dispenses semaglutide and tirzepatide from $197/month, which makes it the fair comparison to run before you commit here.
What HumeCare+ dispenses
HumeCare+ prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at HumeCare+ at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Before you start an intake, ask HumeCare+ which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. We found no FDA warning letters issued to HumeCare+. The pharmacy question matters most here because the medication is compounded. If HumeCare+ will not name the pharmacy, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether HumeCare+ bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
Our read
HumeCare+ lands mid-market on price. The catch is disclosure, which is why HumeCare+ scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
HumeCare+ falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay HumeCare+
Starting at $199 a month. Check today's price, then start the intake.
Where HumeCare+ is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider Oak.
Alternatives to HumeCare+
Editorial score · methodology
Editorial score · methodology
Bodybuilding Health+
Best for: seeing what it charges before you answer any medical questions
Editorial score · methodology
Compare HumeCare+ head to head
The sellers closest to HumeCare+ on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this HumeCare+ review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See HumeCare+'s current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.